An announcement from Cytosorbents Corp (CTSO) is now available.
CytoSorbents Corporation has launched a voluntary salary reduction program as a cost-saving measure, with top executives including the CEO and CFO taking pay cuts up to 35%. In exchange for the salary sacrifices that run from April to December 2024, the participants received nonqualified stock options matching the value of their reduced salaries. This strategy aims to align the interests of the executives with those of the shareholders, ensuring a shared focus on the company’s financial health.
For an in-depth examination of CTSO stock, go to TipRanks’ Stock Analysis page.
